BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21903248)

  • 21. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
    Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
    J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.
    Kattan MW; Zelefsky MJ; Kupelian PA; Cho D; Scardino PT; Fuks Z; Leibel SA
    J Clin Oncol; 2003 Dec; 21(24):4568-71. PubMed ID: 14673043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women.
    Macdonald OK; Sause WT; Lee RJ; Lee CM; Dodson MK; Zempolich K; Gaffney DK
    Gynecol Oncol; 2006 Nov; 103(2):661-6. PubMed ID: 16797682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer.
    Patel S; Portelance L; Gilbert L; Tan L; Stanimir G; Duclos M; Souhami L
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1438-45. PubMed ID: 17418961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ
    BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.
    Jereczek-Fossa BA; Badzio A; Jassem J
    Radiother Oncol; 2004 Aug; 72(2):175-81. PubMed ID: 15297136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.
    Svatek R; Karakiewicz PI; Shulman M; Karam J; Perrotte P; Benaim E
    Eur Urol; 2006 Apr; 49(4):666-74. PubMed ID: 16423446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
    Zaak D; Burger M; Otto W; Bastian PJ; Denzinger S; Stief CG; Buchner H; Hartmann A; Wieland WF; Shariat SF; Fritsche HM
    BJU Int; 2010 Aug; 106(3):342-8. PubMed ID: 20002664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
    Jeldres C; Sun M; Lughezzani G; Isbarn H; Shariat SF; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Cancer; 2010 Aug; 116(16):3774-84. PubMed ID: 20564085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a prognostic nomogram for identifying those factors which influence the 2- and 5-year survival chances of Taiwanese women diagnosed with breast cancer.
    Fan YP; Liu CL; Chiang IJ; Lin CY
    Eur J Cancer Care (Engl); 2011 Sep; 20(5):620-6. PubMed ID: 21410802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
    Suardi N; Porter CR; Reuther AM; Walz J; Kodama K; Gibbons RP; Correa R; Montorsi F; Graefen M; Huland H; Klein EA; Karakiewicz PI
    Cancer; 2008 Mar; 112(6):1254-63. PubMed ID: 18286530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of adjuvant treatment in endometrial cancer.
    Schmitt G; Carl UM; Pape H; Vernimmen FJ
    Strahlenther Onkol; 1994 Oct; 170(10):561-4. PubMed ID: 7974166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a nomogram for predicting survival after resection for adenocarcinoma of the pancreas.
    de Castro SM; Biere SS; Lagarde SM; Busch OR; van Gulik TM; Gouma DJ
    Br J Surg; 2009 Apr; 96(4):417-23. PubMed ID: 19283741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
    Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
    Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
    Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K
    Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
    Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
    Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of adjuvant therapy in patients with FIGO stage III endometrial carcinoma: a multicenter retrospective study.
    Marchetti C; Pisano C; Mangili G; Lorusso D; Panici PB; Silvestro G; Candiani M; Greggi S; Perniola G; Di Maio M; Pignata S
    Oncology; 2011; 81(2):104-12. PubMed ID: 21986449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.